Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica A Slavin

Showing results (71-80 of 281) with videos related to

Pageof 29
Sort By:
Mycoses|April 18, 2015
Multi-triazole-resistant Aspergillus fumigatus infections in AustraliaSarah E Kidd, Emma Goeman, Jacques F Meis, et al.
Journal of Microbiological Methods|June 16, 2009
Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modificationsSarah E Kidd, Nik A A Nik Zulkepeli, Monica A Slavin, et al.
Medical Mycology|April 5, 2023
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortalityCaitlin Keighley, Alun L Pope, Debbie Marriott, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2026
Diagnosis and risk factors for invasive mould disease-a round table discussion on directing antifungal therapy according to the available evidenceAna Alastruey-Izqueirdo, Johan Maertens, Monica A Slavin, et al.
BMJ Open|May 7, 2026
Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocolGemma K Reynolds, Mary Ann Anderson, Karin Thursky, et al.
Blood Reviews|May 1, 2018
Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapiesBenjamin W Teh, Constantine S Tam, Sasanka Handunnetti, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2026
25 years of improvement in mortality in invasive aspergillosis in haematology patients: will it be sustained or is it under threat?Johan A Maertens, Yuri Vanbiervliet, Toine Mercier, et al.
Blood Advances|July 26, 2024
Improving infection reporting in hematology treatment trialsBenjamin W Teh, Gemma K Reynolds, Malgorzata Mikulska, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2024
Antimicrobial use and appropriateness in neutropenic fever: a study of the Hospital National Antimicrobial Prescribing Survey dataNikhil Singh, Abby P Douglas, Monica A Slavin, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation TherapiesChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Pageof 29

Showing results (71-80 of 281) with videos related to

Sort By:
Pageof 29
Mycoses|April 18, 2015
Multi-triazole-resistant Aspergillus fumigatus infections in AustraliaSarah E Kidd, Emma Goeman, Jacques F Meis, et al.
Journal of Microbiological Methods|June 16, 2009
Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modificationsSarah E Kidd, Nik A A Nik Zulkepeli, Monica A Slavin, et al.
Medical Mycology|April 5, 2023
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortalityCaitlin Keighley, Alun L Pope, Debbie Marriott, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2026
Diagnosis and risk factors for invasive mould disease-a round table discussion on directing antifungal therapy according to the available evidenceAna Alastruey-Izqueirdo, Johan Maertens, Monica A Slavin, et al.
BMJ Open|May 7, 2026
Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocolGemma K Reynolds, Mary Ann Anderson, Karin Thursky, et al.
Blood Reviews|May 1, 2018
Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapiesBenjamin W Teh, Constantine S Tam, Sasanka Handunnetti, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2026
25 years of improvement in mortality in invasive aspergillosis in haematology patients: will it be sustained or is it under threat?Johan A Maertens, Yuri Vanbiervliet, Toine Mercier, et al.
Blood Advances|July 26, 2024
Improving infection reporting in hematology treatment trialsBenjamin W Teh, Gemma K Reynolds, Malgorzata Mikulska, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2024
Antimicrobial use and appropriateness in neutropenic fever: a study of the Hospital National Antimicrobial Prescribing Survey dataNikhil Singh, Abby P Douglas, Monica A Slavin, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation TherapiesChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Pageof 29